4PPA

ITK kinase domain with compound 11 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)

Summary for 4PPA

Entry DOI	10.2210/pdb4ppa/pdb
Related	4PP9 4PPB 4PPC
Descriptor	Tyrosine-protein kinase ITK/TSK, N-[1-(3-cyanobenzyl)-1H-pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide (2 entities in total)
Functional Keywords	protein kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological source	Homo sapiens (human)
Cellular location	Cytoplasm : Q08881
Total number of polymer chains	2
Total formula weight	61245.81
Authors	Eigenbrot, C.,Shia, S. (deposition date: 2014-02-26, release date: 2014-06-04, Last modification date: 2023-09-20)
Primary citation	Pastor, R.M.,Burch, J.D.,Magnuson, S.,Ortwine, D.F.,Chen, Y.,De La Torre, K.,Ding, X.,Eigenbrot, C.,Johnson, A.,Liimatta, M.,Liu, Y.,Shia, S.,Wang, X.,Wu, L.C.,Pei, Z. Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors. Bioorg.Med.Chem.Lett., 24:2448-2452, 2014 Cited by PubMed: 24767842 DOI: 10.1016/j.bmcl.2014.04.023 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.67 Å)

Structure validation